Ducol Organics & Colours Annual General Meeting
Ducol Organics and Colours Limited held its 32nd Annual General Meeting on September 17, 2026. The company submitted the meeting proceedings, voting results, and Scrutinizer’s report.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
30 announcements with these filters
Ducol Organics and Colours Limited held its 32nd Annual General Meeting on September 17, 2026. The company submitted the meeting proceedings, voting results, and Scrutinizer’s report.
Ducol Organics and Colours Limited has filed a notice for its Annual General Meeting scheduled for September 17, 2026, to conduct regular business.
Ducol Organics and Colours Limited has filed its Annual Report for 2025-26, highlighting business operations, strategic achievements, and financial statements for the fiscal year.
Ducol Organics and Colours Limited has announced the closure of its Register of Members from September 10, 2026, to September 17, 2026, for its 32nd AGM.
Ducol Organics and Colours Limited announced its board meeting outcome. The company approved the Directors Report and scheduled its 32nd Annual General Meeting for September 17, 2026.
Ducol Organics and Colours Limited has scheduled a board meeting for August 20, 2026. The meeting will discuss general business matters.
Ducol Organics filed its investor complaints statement for the quarter ended June 30, 2026. No investor complaints were received or pending during this period.
Ducol Organics allotted 17,64,697 equity shares via preferential issue at Rs. 170 each. The transaction raised approximately Rs. 30 Crore from two investors.
Ducol Organics approved the preferential allotment of 17,64,697 equity shares. The total issue value is ₹18.02 Crore.
Ducol Organics corrected a reporting error in its XBRL financial filing. Paid-up equity capital was inadvertently reported in absolute figures instead of lakhs.
Ducol Organics received NSE in-principle approval for a preferential issue of 17,64,697 equity shares. This will strengthen the company's capital base and fund future growth.
Ducol Organics shareholders approved a preferential issuance of up to 17,64,697 equity shares via share swap. The resolution passed with requisite majority during the June 2026 EGM.
Ducol Organics held an EGM to approve a ₹29.99 Crore preferential equity issue via share swap. This issuance targets shareholders of Xchem Polymer India Private Limited.
Ducol Organics submitted revised financial results following an exchange clarification regarding missing comparative figures. The company attributed the initial omission to a procedural oversight.
Ducol Organics received NSE in-principle approval to list 39,682 equity shares issued on a preferential basis. The shares will be admitted to dealings following depository confirmation.
Ducol Organics acquired a 50.67% stake in Xchem Polymers for ₹38 Crore. This strategic move strengthens its footprint in the specialty construction chemicals segment.
Ducol reports strong H2 FY26 performance with 84.55% consolidated revenue growth, driven by the Bitumag acquisition and entry into the waterproofing/construction chemicals sector.
Ducol Organics reported consolidated FY26 revenue of ₹136.07 Crore and PAT of ₹7.25 Crore. It is also finalizing a ₹75 Crore acquisition of Xchem Polymer India.
Ducol Organics confirmed full utilization of its ₹31.51 Crore IPO proceeds with no deviations reported. Funds were deployed towards working capital and general corporate purposes.
Ducol Organics & Colours Ltd reported revenue from operations of ₹71.6 Cr (+84.5% YoY) and net profit of ₹4.4 Cr (+109.5% YoY) for H2 FY26.
Ducol Organics reported audited FY2026 results and announced the ₹75 Crore acquisition of XCHEM Polymers. The deal involves cash, share swaps, and deferred payments.
Ducol Organics convened an EGM on June 5, 2026, regarding a preferential share issue. The firm plans a 17,64,697 equity share swap with XPIPL shareholders.
Ducol Organics And Colours Limited will hold a board meeting on May 19, 2026. Directors will consider and approve audited financial results for the 2026 fiscal year.
Ducol Organics approved a ₹30.00 Crore preferential share swap issue to public investors. The capital raise strengthens the balance sheet through the issuance of new equity.
Ducol Organics and Colours Limited submitted a compliance certificate confirming the non-applicability of Corporate Governance provisions for the quarter ended March 31, 2026. As an SME-listed entity, the company is exempt under Regulation 15 of SEBI LODR Regulations.
Ducol Organics and Colours Limited submitted its Structural Digital Database (SDD) Compliance Certificate for the financial year ended March 31, 2026. The certificate, issued by practicing company secretaries, confirms the company maintains a non-tamperable database with an audit trail for sensitive information as required under SEBI Insider Trading Regulations.
Ducol Organics and Colours Limited reported zero investor complaints for the quarter ended March 31, 2026. The report, confirmed by Bigshare Services Pvt. Ltd., shows no pending, received, or unresolved grievances during this period, maintaining a clean compliance record.
Ducol Organics And Colours Limited informed the National Stock Exchange that it is exempt from submitting the Annual Secretarial Compliance Report for the financial year ended March 31, 2026. This exemption applies under SEBI Regulation 15(2) as the company's securities are listed on the SME Exchange.
Ducol Organics and Colours Limited clarified to the NSE regarding recent stock price movement. The company confirmed it has disclosed all material information and is not withholding any price-sensitive events. It reaffirmed commitment to timely disclosures under SEBI Regulation 30.
Ducol Organics And Colours Limited submitted an undertaking regarding the non-applicability of Corporate Governance regulations for the year ended March 31, 2026. As an SME-listed entity, the company is exempted under Regulation 15 of SEBI (LODR) Regulations, 2015. This is a routine regulatory compliance filing.